Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06546241 · ClinicalTrials.gov registry record · Early Phase 1

Celebrandome: Preliminary Study

A Early Phase 1 study of Body Image and Self Esteem, sponsored by Arizona State University.

Completed
Registry status
Early Phase 1
Development phase
154
Enrollment target
1
Study location

NCT06546241: Completed Early Phase 1 study of Body Image and Self Esteem, sponsored by Arizona State University.

NCT06546241 is a Early Phase 1 study of Body Image and Self Esteem that has completed, run by Arizona State University. The registered enrollment target is 154 participants, below the 296-participant average among 8 other Body Image trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06546241, a Early Phase 1 study of Body Image and Self Esteem, has completed, sponsored by Arizona State University.

COMPLETED
Registry status
Early Phase 1
Development phase
154 participants
Enrollment target
1
Study location

Study Summary

The Dove Self Esteem Project, has provided our research team with funding to develop a 60- minute workshop for Hispanic/Latinx Youth between the ages of 11 to 16 years old that builds body confidence. This workshop was developed based on prior curriculum the investigator has developed for The Dove Self Esteem Project and designed with two teachers and several adolescent children. The aims of the current study are to: 1) examine the efficacy of the workshop, and 2.) evaluate the extent to which children like the curriculum and find it useful. Children will be randomized to control group or intervention group; however, the control group will eventually go through the workshop after 2 surveys. It is hypothesized that children in the intervention group will report higher body satisfaction scores, greater self- esteem, more awareness of body talk and less engagement in appearance comparisons relative to the control group. It is hypothesized that children will report liking the workshop, finding it useful and engaging.

Primary Outcome

This measure assesses the extent youth like their appearance and the extent they dislike their appearance. Higher scores indicate more self esteem. Instructions are "Right now, please tell us how much this represents you." Items are on a Likert scale from 0 (never) to 4 (Always).

Conditions Studied

Interventions

  • BEHAVIORAL Celebrandome

Study Locations (1)

Arizona

  • Arizona State University - Tempe

Trial Details

FieldValue
Enrollment Target 154 participants
Start Date 2023-04-26
Est. Completion 2023-12-31
Phase Early Phase 1
Arizona State University

187 total trials

What the finished NCT06546241 record still lists

NCT06546241 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 296-participant average among 8 other Body Image trials with a reported enrollment target (48% lower).

The record links to 2 conditions, with Body Image appearing as the primary indexed condition, and to 1 intervention - of which Celebrandome is the first listed.

NCT06546241 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT06546241 about?

NCT06546241 is a clinical study titled "Celebrandome: Preliminary Study". The Dove Self Esteem Project, has provided our research team with funding to develop a 60- minute workshop for Hispanic/Latinx Youth between the ages of 11 to 16 years old that builds body confidence. This workshop was developed based on prior curriculum the investigator has developed for The Dove S...

What is the current status of trial NCT06546241?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 154 participants. The study started on 2023-04-26. Estimated completion is 2023-12-31.

What conditions does trial NCT06546241 study?

This clinical trial studies the following conditions: Body Image, Self Esteem.

What interventions are being tested in trial NCT06546241?

The interventions under investigation include: Celebrandome (BEHAVIORAL).

Who is sponsoring clinical trial NCT06546241?

This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06546241 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Image

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06546241's enrollment target sits among peer trials

154 4th of 8 higher than 5 of 8 other Body Image trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Body Image trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04300998 · 154 participants

    Study of CAR-T Therapy in Older Patients

  • NCT04597372 · 154 participants · Phase 2

    Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery

  • NCT05294042 · 154 participants · NA

    Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities

  • NCT05512390 · 154 participants · Phase 1

    A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06546241, the US trial registry maintained by the National Library of Medicine. NCT06546241 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.